BlueSphere Bio was founded to unlock the potential of personalized T cell therapy for the treatment of cancer by harnessing the unique specificity of each patient’s own T cells for the particular molecular fingerprint of each patient’s own cancer through our novel TCXpress technology.
Our proprietary TCXpress platform is an elegant, rapid approach that exploits the patient’s own immune defenses to attack their cancer specifically, and is designed to leave normal tissues untouched, thereby reducing harmful side effects.
The platform and implementation allows us to deliver rapid, personalized T cell treatments for a variety of cancer indications.
Company Details
- Employees
- 41
- Founded
- -
- Address
- 350 Technology Drive,
- CO****@****BIO.COM
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bluespherebio.com
- HQ
- Pittsburgh, PA
Bluesphere Bio Questions
Bluesphere Bio's website is bluespherebio.com
Bluesphere Bio's LinkedIn profile is https://www.linkedin.com/company/bluesphere-bio
Bluesphere Bio has
41 employees.
View email and phone details for 41
employees at Bluesphere Bio.
Bluesphere Bio's industry is
Biotechnology Research
Bluesphere Bio's top competitors are
Peptilogics,
Vertex Pharmaceuticals,
Noveome Biotherapeutics, Inc.,
Sarepta Therapeutics,
Spark Therapeutics, Inc.,
Cognition Therapeutics, Inc.,
Avista Therapeutics,
Novasenta,
Carmell Cosmetics,
Krystal Biotech, Inc..
Bluesphere Bio's support email address is CONTACT@BLUESPHEREBIO.COM
Bluesphere Bio's categories are Biotechnology Research
Bluesphere Bio's founding year is 2018
